Home › Neoplasie del sangue › Tennessee › Nashville
Studi clinici su Neoplasie del sangue a Nashville, TN
13 studi su Neoplasie del sangue cercano partecipanti presso sedi a Nashville e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
In reclutamentoFase 3
- Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville
- Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0015), Nashville
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
In reclutamentoFase 1
- Sarah Cannon Cancer Institute, Nashville
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
In reclutamentoFase 3
- Quetzal Site 12, Nashville
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
In reclutamentoFase 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
In reclutamentoFase 3
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- Vanderbilt University Medical Center, Nashville
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
In reclutamentoFase 1
- Sarah Cannon Research Institute - Oncology Partners, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
In reclutamentoFase 2
- Vanderbilt University, Ingram Cancer Center, Nashville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Vanderbilt University, Nashville
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
In reclutamentoFase 3
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
In reclutamentoFase 1
- TriStar Bone Marrow Transplant, Nashville
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
In reclutamentoFase 1/2
- SCRI Oncology Partners, Nashville
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
In reclutamentoFase 1
- TriStar Bone Marrow Transplant, Nashville
Studi su Neoplasie del sangue in altre città
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Washington, DC19 studi
- Seattle, WA18 studi
- Baltimore, MD18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Edison, NJ13 studi
- Columbus, OH13 studi
Altri studi a Nashville
- Cancro del polmone non a piccole cellule97 studi
- Cancro al seno81 studi
- Cancro metastatico70 studi
- Cancro colorettale69 studi
- Cancro (tutti i tipi)65 studi
- Cancro ovarico49 studi
- Cancro alla prostata43 studi
- Cancro ai polmoni40 studi
- Carcinoma a cellule squamose della testa e del collo39 studi
- Cancro pancreatico39 studi
- Cancro dell'endometrio38 studi
- Melanoma33 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.